Floating Button
Home Capital Broker's Calls

'Sell' Sembmarine as vaccine news are only a placebo: UOBKH

Jeffrey Tan
Jeffrey Tan • 2 min read
'Sell' Sembmarine as vaccine news are only a placebo: UOBKH
Sembmarine’s financials are likely to deteriorate further given that it has not won new orders this year, says UOB KayHian.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Investors, who are turning bullish on Sembcorp Marine (Sembmarine) given the positive Covid-19 vaccine news, may need to dial down their optimism.

Sembmarine’s financials are likely to deteriorate further given that it has not won new orders this year, according to UOB KayHian.

Worse, the company is witnessing delivery delays into 2021, which will negatively impact its near-term working capital and cash flow, the brokerage warns.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.